0002025735-26-000001.txt : 20260717 0002025735-26-000001.hdr.sgml : 20260717 20260717140448 ACCESSION NUMBER: 0002025735-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260717 DATE AS OF CHANGE: 20260717 EFFECTIVENESS DATE: 20260717 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aspicio Therapeutics, Inc. CENTRAL INDEX KEY: 0002025735 ORGANIZATION NAME: EIN: 990883354 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-591330 FILM NUMBER: 261183098 BUSINESS ADDRESS: STREET 1: 250 TRUMAN WAY CITY: DOWNINGTOWN STATE: PA ZIP: 19335 BUSINESS PHONE: 484.885.4744 MAIL ADDRESS: STREET 1: 250 TRUMAN WAY CITY: DOWNINGTOWN STATE: PA ZIP: 19335 D 1 primary_doc.xml X0708 D LIVE 0002025735 Aspicio Therapeutics, Inc. 250 TRUMAN WAY DOWNINGTOWN PA PENNSYLVANIA 19335 484.885.4744 DELAWARE None None Corporation true 2024 Michael Keane 250 Truman Way Downingtown PA PENNSYLVANIA 19335 Executive Officer Director Other Health Care Decline to Disclose 06b false 2026-07-16 false true false 0 200000 200000 0 false 2 0 0 0 false Aspicio Therapeutics, Inc. /s/Michael Keane Michael Keane President 2026-07-15